Global Medical Food Market Report 2022: Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers to Boost Growth Opportunities
28 oct. 2022 05h58 HE
|
Research and Markets
Dublin, Oct. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Medical Food Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study aims to understand the role of a...
Functional Foods and Beverages Global Market Report 2022: Featuring Abbott, Coca-Cola, Kraft, Unilever, Nestlé, BASF & More
03 oct. 2022 07h43 HE
|
Research and Markets
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Functional Foods and Beverages: Global Markets 2022-2027" report has been added to ResearchAndMarkets.com's offering.The global market for functional...
$29.2 Billion Worldwide Medical Foods Industry to 2027 - Featuring Abbott Laboratories, Danone and Meiji Holdings Among Others
19 juil. 2022 05h53 HE
|
Research and Markets
Dublin, July 19, 2022 (GLOBE NEWSWIRE) -- The "Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Medical Foods Markets, 2019-2029 with 2020 as the Base Year
22 juin 2021 06h18 HE
|
Research and Markets
Dublin, June 22, 2021 (GLOBE NEWSWIRE) -- The "Medical Foods Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021...
Food for Special Medical Purpose (FSMP) Market is projected to reach US $19.41 Billion by 2030: Visiongain Research. Ltd.
31 mai 2021 11h30 HE
|
Visiongain Ltd
Visiongain has published a new report onGlobal Food for Special Medical Purposes (FSMP) Market Report 2020-2030: Value Forecasts by Type (Nutritionally Complete Food, Nutritionally Complete Foods with...
Global Medical Foods for Inborn Errors of Metabolism Market to 2027 - by Product, Age group, Disease, Forms, Packaging, Distribution Channel and Geography
02 oct. 2020 06h09 HE
|
Research and Markets
Dublin, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The "Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Age group; Disease; Forms;...
fMRI Data from Clinical Trial Demonstrate a Proposed Mechanism of Action for the Efficacy of Vayarin® Plus in Adults with ADHD
22 janv. 2019 08h20 HE
|
VAYA Pharma Inc.
Study Abstract Presented at the 2019 APSARD Annual Meeting in Washington, DC COLUMBIA, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc, and...
CORRECTING and REPLACING -- Improved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi-Year, Real-World Retrospective Study
24 janv. 2017 13h03 HE
|
VAYA Pharma Inc.
BALTIMORE, Jan. 24, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline January 10, 2017 by VAYA Pharma, please note that in the first paragraph under Results at a Glance, "38...
Improved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi-Year, Real-World Retrospective Study
10 janv. 2017 11h33 HE
|
VAYA Pharma Inc.
BALTIMORE, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Up to 75 percent of individuals with Attention Deficit Hyperactivity Disorder (ADHD) experience emotional dysregulation, according to Research in...
Entia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses
02 nov. 2016 15h20 HE
|
Entia Biosciences, Inc.
PORTLAND, Ore., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) has been informed that the European Patent Office has granted European Patent Number 1 761 784 with the title...